XMAG Outperforms S&P 500 While MAGS Struggles in 2026
In 2026, the Defiance Large Cap ex-Mag 7 ETF (NASDAQ: XMAG) has emerged as a strong performer, returning 16% year-to-date, while the Roundhill Magnificent Seven ETF (CBOE: MAGS) has lagged behind with a mere 5% increase. This performance gap is particularly notable given that MAGS was designed to provide equal-weighted exposure to the seven mega-cap stocks that have driven the S&P 500's growth over the past few years.
Since its launch on April 11, 2023, MAGS has delivered impressive returns, totaling 190.29% through August 7, 2026. However, 2026 has presented a different challenge for MAGS, which has only managed a year-to-date increase of 4.82%, falling short of both the S&P 500 and XMAG. The primary factor contributing to MAGS's underperformance is the significant decline of Tesla, which is one of the seven stocks in the fund. Tesla's stock has dropped 26.94% this year, negatively impacting MAGS's overall performance.
For Your Trading Desk
Sponsor Spike Success.
Structurally, MAGS is unique for an equity fund, with only 34% of its net assets invested in actual equities. The majority of its assets, approximately 53%, are held in Treasury bills, while the remainder is allocated to swap derivatives. This unusual structure means that MAGS's returns are influenced not only by the performance of the underlying stocks but also by the pricing of the swap contracts.
In contrast, XMAG tracks the BITA US 500 ex-Magnificent 7 Index and has an expense ratio of 0.35%. As of May 31, 2026, XMAG has approximately $175.40 million in assets and maintains a diversified portfolio that includes significant positions in companies like Broadcom, Micron, and Eli Lilly. By excluding the seven largest stocks, XMAG captures a broader segment of the market that has been performing well in 2026.
Over the past year, XMAG has returned 24.37%, outperforming MAGS, which has only achieved 18.99%. Investors in MAGS are effectively making a concentrated bet on seven stocks, while those in XMAG benefit from exposure to around 500 large-cap companies, thereby mitigating the risks associated with the performance of the Magnificent Seven.
However, XMAG also comes with its own trade-offs. Should the Magnificent Seven regain their leadership in the market, XMAG is likely to lag behind due to its design. Additionally, XMAG is smaller than MAGS, with net assets of approximately $143 million compared to MAGS's $3.5 billion, which could affect trading costs for larger orders.
For investors already holding a broad S&P 500 fund alongside MAGS, adding XMAG can help diversify their exposure without increasing concentration in the Magnificent Seven. The most tax-efficient strategy for reallocating investments between these funds involves using a tax-advantaged account to avoid capital gains taxes.
Ultimately, the decision to shift investments from MAGS to XMAG hinges on the investor's current portfolio composition and their confidence in the future performance of the Magnificent Seven. As the broader S&P 500 continues to show strength in 2026, XMAG presents a compelling option for those looking to diversify their holdings away from the concentrated risk of the mega-cap stocks.




